| DC Field | Value | Language |
|---|
| dc.contributor.author | Pakina, V. A. | - |
| dc.contributor.author | Iksanova, E. Z. | - |
| dc.contributor.author | Shikh, E. V. | - |
| dc.contributor.author | Tumutolova, O. M. | - |
| dc.contributor.author | Arutiunian, K. K. | - |
| dc.date.accessioned | 2024-08-23T08:55:42Z | - |
| dc.date.available | 2024-08-23T08:55:42Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | An effective way for targeting EGFR-mediated carcinogenesis: an in vitro study / V.A. Pakina, E.Z. Iksanova, E.V. Shikh [et al.] // Research Results in Pharmacology. - 2024. - Vol.10, №2.-P. 17-26. - Doi: 10.18413/rrpharmacology.10.453. - Refer.: p. 24-25. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/63424 | - |
| dc.description.abstract | EGFR-activating overexpression or somatic mutations are common in different human cancers. In this regard, the search for promising ways to control the carcinogenic transformation of tumor cells and the progression of malignant tumors expressing EGFR seems to be one of the most promising and developing areas of modern molecular pathology and pharmacology | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | cytotoxicity | ru |
| dc.subject | EGFR-mediated carcinogenesis | ru |
| dc.subject | LHT-17-19 | ru |
| dc.subject | pyridine compound | ru |
| dc.subject | tumor cell cultures | ru |
| dc.title | An effective way for targeting EGFR-mediated carcinogenesis: an in vitro study | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 10, № 2
|
